Your browser doesn't support javascript.
loading
Long-Term Opioid Therapy Among Patients With Systemic Lupus Erythematosus in the Community: A Lupus Midwest Network (LUMEN) Study.
Figueroa-Parra, Gabriel; Jeffery, Molly M; Dabit, Jesse Y; Chevet, Baptiste; Valenzuela-Almada, Maria O; Hocaoglu, Mehmet; Osei-Onomah, Shirley-Ann; Kurani, Shaheen; Vallejo, Sebastian; Achenbach, Sara J; Hooten, W Michael; Barbour, Kamil E; Crowson, Cynthia S; Duarte-García, Alí.
Afiliação
  • Figueroa-Parra G; G. Figueroa-Parra, MD, J.Y. Dabit, MD, MS, M.O. Valenzuela-Almada, MD, M. Hocaoglu, MD, S.A. Osei-Onomah, MPH, S. Vallejo, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA.
  • Jeffery MM; M.M. Jeffery, PhD, Division of Health Care Delivery Research, Mayo Clinic, Rochester, Minnesota, USA.
  • Dabit JY; G. Figueroa-Parra, MD, J.Y. Dabit, MD, MS, M.O. Valenzuela-Almada, MD, M. Hocaoglu, MD, S.A. Osei-Onomah, MPH, S. Vallejo, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA.
  • Chevet B; B. Chevet, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA, and Division of Rheumatology, Brest Teaching Hospital, LBAI, UMR1227, Univ Brest, Inserm, CHU de Brest, Brest, France.
  • Valenzuela-Almada MO; G. Figueroa-Parra, MD, J.Y. Dabit, MD, MS, M.O. Valenzuela-Almada, MD, M. Hocaoglu, MD, S.A. Osei-Onomah, MPH, S. Vallejo, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA.
  • Hocaoglu M; G. Figueroa-Parra, MD, J.Y. Dabit, MD, MS, M.O. Valenzuela-Almada, MD, M. Hocaoglu, MD, S.A. Osei-Onomah, MPH, S. Vallejo, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA.
  • Osei-Onomah SA; G. Figueroa-Parra, MD, J.Y. Dabit, MD, MS, M.O. Valenzuela-Almada, MD, M. Hocaoglu, MD, S.A. Osei-Onomah, MPH, S. Vallejo, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA.
  • Kurani S; S. Kurani, PhD, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA.
  • Vallejo S; G. Figueroa-Parra, MD, J.Y. Dabit, MD, MS, M.O. Valenzuela-Almada, MD, M. Hocaoglu, MD, S.A. Osei-Onomah, MPH, S. Vallejo, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA.
  • Achenbach SJ; S.J. Achenbach, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.
  • Hooten WM; W.M. Hooten, MD, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Barbour KE; K.E. Barbour, PhD, MPH, MS, Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Crowson CS; C.S. Crowson, PhD, Division of Rheumatology, Mayo Clinic, and Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.
  • Duarte-García A; A. Duarte-García, MD, MSc, Division of Rheumatology, Mayo Clinic, and Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. duarte.ali@mayo.edu.
J Rheumatol ; 50(4): 504-511, 2023 04.
Article em En | MEDLINE | ID: mdl-36379579

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pericardite / Fibromialgia / Fraturas Ósseas / Lúpus Eritematoso Sistêmico Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pericardite / Fibromialgia / Fraturas Ósseas / Lúpus Eritematoso Sistêmico Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article